{"id":5670,"date":"2024-03-26T06:39:12","date_gmt":"2024-03-26T11:39:12","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5670"},"modified":"2025-06-27T11:20:37","modified_gmt":"2025-06-27T16:20:37","slug":"nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ar\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/","title":{"rendered":"\u062a\u0639\u0644\u0646 \u0634\u0631\u0643\u0629 Nanscope Therapeutics \u0639\u0646 \u0646\u062a\u0627\u0626\u062c \u0625\u064a\u062c\u0627\u0628\u064a\u0629 \u0645\u0646 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0645\u0639\u0634\u0627\u0629 \u0630\u0627\u062a \u0627\u0644\u0634\u0648\u0627\u0647\u062f \u0644\u0639\u0642\u0627\u0631 MCO-010 \u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<h1><\/h1>\n<ul type=\"disc\">\n<li><strong><i>\u062d\u0642\u0642 MCO-010 \u0646\u0642\u0627\u0637 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u064a\u0629 \u0648\u0627\u0644\u062b\u0627\u0646\u0648\u064a\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629 \u0630\u0627\u062a \u0627\u0644\u0623\u0647\u0645\u064a\u0629 \u0627\u0644\u0625\u062d\u0635\u0627\u0626\u064a\u0629 \u0648\u0639\u062f\u0645 \u0648\u062c\u0648\u062f \u0623\u062d\u062f\u0627\u062b \u0633\u0644\u0628\u064a\u0629 \u062e\u0637\u064a\u0631\u0629<\/i><\/strong><\/li>\n<li><strong><i>\u0628\u064a\u0627\u0646\u0627\u062a \u0645\u0646 \u0627\u0644\u0645\u0631\u062d\u0644\u0629\u00a0<span class=\"xn-money\">2\u0628<\/span>\u00a0\u062a\u064f\u0638\u0647\u0631 \u062a\u062c\u0631\u0628\u0629 RESTORE \u062a\u062d\u0633\u0646\u064b\u0627 \u0630\u0627 \u0645\u0639\u0646\u0649 \u0633\u0631\u064a\u0631\u064a\u064b\u0627 \u0641\u064a \u0627\u0644\u0631\u0624\u064a\u0629 \u0644\u062f\u0649 \u0627\u0644\u0623\u0641\u0631\u0627\u062f \u0627\u0644\u0645\u0643\u0641\u0648\u0641\u064a\u0646 \u0642\u0627\u0646\u0648\u0646\u064a\u064b\u0627 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u062a\u0646\u0643\u0633 \u0639\u0635\u0628\u064a \u062a\u0642\u062f\u0645\u064a \u0648\u062f\u0627\u0626\u0645 \u0641\u064a \u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0639\u064a\u0646<\/i><\/strong><\/li>\n<li><strong><i>RESTORE \u0647\u064a \u0623\u0648\u0644 \u062a\u062c\u0631\u0628\u0629 \u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u0648\u0645\u0636\u0628\u0648\u0637\u0629 \u0644\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u0627\u0644\u0644\u0627\u0625\u0631\u0627\u062f\u064a \u0644\u0644\u0637\u0641\u0631\u0629 \u0644\u0645\u0631\u0636 \u0648\u0631\u0627\u062b\u064a<\/i><\/strong><\/li>\n<li><strong><i>\u062a\u062a\u0648\u0642\u0639 \u0634\u0631\u0643\u0629 Nanscope \u062a\u0642\u062f\u064a\u0645 \u0637\u0644\u0628 \u062a\u0631\u062e\u064a\u0635 \u0627\u0644\u0628\u064a\u0648\u0644\u0648\u062c\u064a\u0627 (BLA) \u0625\u0644\u0649 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 (FDA) \u0641\u064a \u0627\u0644\u0646\u0635\u0641 \u0627\u0644\u062b\u0627\u0646\u064a \u0645\u0646 \u0639\u0627\u0645 2024<\/i><\/strong><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<article class=\"news-release inline-gallery-template\">\n<section class=\"release-body container\">\n<div class=\"row\">\n<div class=\"col-lg-10 col-lg-offset-1\">\n<p><span class=\"xn-location\">\u062f\u0627\u0644\u0627\u0633<\/span>,\u00a0<span class=\"xn-chron\">26 \u0645\u0627\u0631\u0633 2024<\/span> \u2014\u00a0<a href=\"http:\/\/nanostherapeutics.com\/ar\/\" target=\"_blank\" rel=\"nofollow noopener\">\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u0644\u0644\u0639\u0644\u0627\u062c\u0627\u062a<\/a>\u060c \u0648\u0647\u064a \u0634\u0631\u0643\u0629 \u0644\u0644\u062a\u0643\u0646\u0648\u0644\u0648\u062c\u064a\u0627 \u0627\u0644\u062d\u064a\u0648\u064a\u0629 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0641\u064a \u0645\u0631\u0627\u062d\u0644\u0647\u0627 \u0627\u0644\u0623\u062e\u064a\u0631\u0629 \u062a\u0639\u0645\u0644 \u0639\u0644\u0649 \u062a\u0637\u0648\u064a\u0631 \u0639\u0644\u0627\u062c\u0627\u062a \u062c\u064a\u0646\u064a\u0629 \u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0645\u0648\u0631\u0648\u062b\u0629 \u0648\u0627\u0644\u062a\u0646\u0643\u0633 \u0627\u0644\u0628\u0642\u0639\u064a \u0627\u0644\u0645\u0631\u062a\u0628\u0637 \u0628\u0627\u0644\u0639\u0645\u0631 (AMD)\u060c \u0623\u0639\u0644\u0646\u062a \u0627\u0644\u064a\u0648\u0645 \u0639\u0646 \u0646\u062a\u0627\u0626\u062c \u0625\u064a\u062c\u0627\u0628\u064a\u0629 \u0628\u0639\u062f \u0627\u0644\u0627\u0646\u062a\u0647\u0627\u0621 \u0645\u0646 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062a\u064a \u0627\u0633\u062a\u0645\u0631\u062a \u0639\u0627\u0645\u064a\u0646\u00a0<span class=\"xn-money\">2\u0628<\/span>\u00a0\u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0627\u0644\u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u0627\u0644\u062e\u0627\u0636\u0639\u0629 \u0644\u0644\u0631\u0642\u0627\u0628\u0629 \u0644\u0628\u0631\u0646\u0627\u0645\u062c\u0647\u0627 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u060c MCO-010<i>,<\/i>\u00a0\u0639\u0644\u0627\u062c \u062c\u064a\u0646\u064a \u0645\u062d\u0627\u064a\u062f \u0644\u0644\u0637\u0641\u0631\u0629 \u0644\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0627\u0644\u0628\u0635\u0631 \u0627\u0644\u062f\u0627\u0626\u0645 \u0648\u0627\u0644\u0634\u062f\u064a\u062f \u0628\u0633\u0628\u0628 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a \u0627\u0644\u0645\u062a\u0642\u062f\u0645 (RP).<\/p>\n<p>\u062d\u0642\u0642\u062a \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0646\u0642\u0637\u0629 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u064a\u0629\u060c \u0645\u0645\u0627 \u064a\u062f\u0644 \u0639\u0644\u0649 \u062a\u062d\u0633\u0646 \u0630\u064a \u062f\u0644\u0627\u0644\u0629 \u0625\u062d\u0635\u0627\u0626\u064a\u0629 \u0641\u064a \u062d\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0627\u0644\u0623\u0641\u0636\u0644 \u062a\u0635\u062d\u064a\u062d\u064b\u0627 (BCVA) \u0641\u064a \u0627\u0644\u0623\u0633\u0628\u0648\u0639 52 \u0641\u064a \u0643\u0644 \u0645\u0646 \u0627\u0644\u062c\u0631\u0639\u0629 \u0627\u0644\u0639\u0627\u0644\u064a\u0629 (0.337 LogMAR\u061b p = 0.021) \u0648\u0627\u0644\u062c\u0631\u0639\u0629 \u0627\u0644\u0645\u0646\u062e\u0641\u0636\u0629 (0.382 LogMAR\u061b p = 0.029) \u0645\u062c\u0645\u0648\u0639\u0627\u062a \u0627\u0644\u0639\u0644\u0627\u062c \u0645\u0642\u0627\u0631\u0646\u0629 \u0628\u0645\u062c\u0645\u0648\u0639\u0629 \u0627\u0644\u062a\u062d\u0643\u0645 \u0627\u0644\u0648\u0647\u0645\u064a\u0629 (0.050 LogMAR). \u0627\u0644\u0645\u0631\u062d\u0644\u0629\u00a0<span class=\"xn-money\">2\u0628<\/span>\u00a0\u062a\u0645\u062b\u0644 \u062a\u062c\u0631\u0628\u0629 RESTORE \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u0627\u0644\u0645\u0636\u0628\u0648\u0637\u0629 \u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0641\u064a \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u062a\u0646\u0643\u0633 \u0627\u0644\u0634\u0628\u0643\u064a \u0627\u0644\u062a\u064a \u0623\u0638\u0647\u0631\u062a \u062a\u062d\u0633\u0646\u064b\u0627 \u064a\u062a\u062c\u0627\u0648\u0632 \u0639\u062a\u0628\u0629 BCVA \u0627\u0644\u0645\u0647\u0645\u0629 \u0633\u0631\u064a\u0631\u064a\u064b\u0627 &gt; 0.3 LogMAR \u0628\u0637\u0631\u064a\u0642\u0629 \u0630\u0627\u062a \u062f\u0644\u0627\u0644\u0629 \u0625\u062d\u0635\u0627\u0626\u064a\u0629.<\/p>\n<p>\u0627\u0633\u062a\u0645\u0631\u062a \u0627\u0644\u062a\u062d\u0633\u064a\u0646\u0627\u062a \u0641\u064a \u0627\u0644\u0648\u0638\u064a\u0641\u0629 \u0627\u0644\u0628\u0635\u0631\u064a\u0629 \u0623\u0648 \u0632\u0627\u062f\u062a \u0628\u0639\u062f \u0627\u0644\u0623\u0633\u0628\u0648\u0639 52 \u0645\u0646 \u0627\u0644\u062f\u0631\u0627\u0633\u0629\u060c \u0645\u0645\u0627 \u064a\u062f\u0644 \u0639\u0644\u0649 \u0627\u0644\u062a\u0623\u062b\u064a\u0631 \u0627\u0644\u062f\u0627\u0626\u0645 \u0644\u062d\u0642\u0646\u0629 \u0648\u0627\u062d\u062f\u0629 \u062f\u0627\u062e\u0644 \u0627\u0644\u062c\u0633\u0645 \u0627\u0644\u0632\u062c\u0627\u062c\u064a \u0644\u0640 MCO-010. \u0643\u0627\u0646 \u062a\u062d\u0633\u0646 BCVA \u0641\u064a \u0627\u0644\u0623\u0633\u0628\u0648\u0639 76\u060c \u0648\u0647\u0648 \u0646\u0642\u0637\u0629 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u062b\u0627\u0646\u0648\u064a\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\u060c \u0630\u0648 \u062f\u0644\u0627\u0644\u0629 \u0625\u062d\u0635\u0627\u0626\u064a\u0629 \u0641\u064a \u0645\u062c\u0645\u0648\u0639\u0629 \u0627\u0644\u0639\u0644\u0627\u062c \u0628\u062c\u0631\u0639\u0629 \u0639\u0627\u0644\u064a\u0629 \u0645\u0642\u0627\u0631\u0646\u0629 \u0628\u0627\u0644\u0645\u062c\u0645\u0648\u0639\u0629 \u0627\u0644\u0636\u0627\u0628\u0637\u0629 (0.539 LogMAR\u061b p = 0.001). \u0641\u064a \u0627\u0644\u0623\u0633\u0628\u0648\u0639 76\u060c \u0644\u0645 \u064a\u0643\u0646 \u0627\u0644\u062a\u062d\u0633\u0646 \u0641\u064a BCVA \u0641\u064a \u0645\u062c\u0645\u0648\u0639\u0629 \u0627\u0644\u0639\u0644\u0627\u062c \u0628\u062c\u0631\u0639\u0629 \u0645\u0646\u062e\u0641\u0636\u0629 \u0630\u0648 \u062f\u0644\u0627\u0644\u0629 \u0625\u062d\u0635\u0627\u0626\u064a\u0629 \u0645\u0642\u0627\u0631\u0646\u0629 \u0628\u0627\u0644\u062a\u062d\u0643\u0645 (0.374 LogMAR\u061b p = 0.065)<i>.<\/i>\u00a0\u062a\u062a\u0648\u0627\u0641\u0642 \u0647\u0630\u0647 \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0645\u0639 \u0645\u0627 \u062a\u0645\u062a \u0645\u0644\u0627\u062d\u0638\u062a\u0647 \u0633\u0627\u0628\u0642\u064b\u0627 \u0641\u064a \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u0633\u0627\u0628\u0642\u0629 \u0645\u0646 \u0627\u0644\u062f\u0631\u0627\u0633\u0629 \u0627\u0644\u0645\u0641\u062a\u0648\u062d\u0629 \u0644\u0644\u0645\u0631\u062d\u0644\u0629 1\/2 \u0623. \u0648\u0645\u0646 \u0627\u0644\u0645\u0642\u0631\u0631 \u0623\u0646 \u062a\u0643\u0648\u0646 \u0627\u0644\u062c\u0631\u0639\u0629 \u0627\u0644\u0639\u0627\u0644\u064a\u0629 MCO-010 (1.2E11gc\/eye) \u0647\u064a \u0627\u0644\u062c\u0631\u0639\u0629 \u0627\u0644\u062a\u062c\u0627\u0631\u064a\u0629.<\/p>\n<p>\u0641\u064a \u0646\u0642\u0637\u0629 \u0646\u0647\u0627\u064a\u0629 \u062b\u0627\u0646\u0648\u064a\u0629 \u0623\u062e\u0631\u0649 \u0645\u062d\u062f\u062f\u0629 \u0645\u0633\u0628\u0642\u064b\u0627\u060c \u0623\u0638\u0647\u0631\u062a \u0646\u0642\u0637\u0629 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u0648\u0638\u064a\u0641\u064a\u0629 \u0627\u0644\u0645\u0631\u0643\u0628\u0629 \u0644\u062a\u0645\u064a\u064a\u0632 \u0627\u0644\u0634\u0643\u0644 \u0645\u062a\u0639\u062f\u062f \u0627\u0644\u0625\u0636\u0627\u0621\u0629 \u0627\u0644\u062c\u062f\u064a\u062f \u0648\u0627\u062e\u062a\u0628\u0627\u0631 \u0627\u0644\u062d\u0631\u0643\u0629 y \u0645\u0639\u062f\u0644 \u0627\u0633\u062a\u062c\u0627\u0628\u0629 89% \u0641\u064a \u0643\u0644 \u0645\u0646 \u0645\u062c\u0645\u0648\u0639\u0627\u062a \u0627\u0644\u0639\u0644\u0627\u062c \u0628\u062c\u0631\u0639\u0629 \u0639\u0627\u0644\u064a\u0629 \u0648\u0645\u0646\u062e\u0641\u0636\u0629 \u0627\u0644\u062c\u0631\u0639\u0629 \u0641\u064a \u0627\u0644\u0623\u0633\u0628\u0648\u0639 52\u060c \u0645\u0645\u0627 \u064a\u0648\u0641\u0631 \u062f\u0639\u0645\u064b\u0627 \u0625\u0636\u0627\u0641\u064a\u064b\u0627 \u0644\u0644\u0631\u0624\u064a\u0629 \u0627\u0644\u062a\u062d\u0633\u0646 \u0628\u0639\u062f \u0625\u062f\u0627\u0631\u0629 MCO-010. \u0633\u064a\u062a\u0645 \u062a\u0642\u062f\u064a\u0645 \u0628\u064a\u0627\u0646\u0627\u062a \u0625\u0636\u0627\u0641\u064a\u0629 \u0645\u0646 \u0647\u0630\u0647 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0641\u064a \u0633\u0644\u0633\u0644\u0629 \u0645\u0646 \u0627\u0644\u0627\u062c\u062a\u0645\u0627\u0639\u0627\u062a \u0627\u0644\u0639\u0644\u0645\u064a\u0629 \u0641\u064a \u0627\u0644\u0623\u0634\u0647\u0631 \u0627\u0644\u0645\u0642\u0628\u0644\u0629\u060c \u0628\u062f\u0621\u0627\u064b \u0628\u0639\u0631\u0636 \u062a\u0642\u062f\u064a\u0645\u064a \u0641\u064a \u0627\u0644\u0627\u062c\u062a\u0645\u0627\u0639 \u0627\u0644\u0639\u0644\u0645\u064a \u0627\u0644\u0633\u0646\u0648\u064a \u0644\u062c\u0645\u0639\u064a\u0629 \u0623\u0628\u062d\u0627\u062b \u0627\u0644\u0631\u0624\u064a\u0629 \u0648\u0637\u0628 \u0627\u0644\u0639\u064a\u0648\u0646 \u062d\u0648\u0644\u00a0<span class=\"xn-chron\">6 \u0645\u0627\u064a\u0648 2024<\/span>\u060c \u0641\u064a\u00a0<span class=\"xn-location\">\u0633\u064a\u0627\u062a\u0644\u060c \u0648\u0627\u0634\u0646\u0637\u0646<\/span>\u060c \u0628\u0648\u0627\u0633\u0637\u0629\u00a0<span class=\"xn-person\">\u0623\u0644\u064a\u0646 \u0647\u0648<\/span>\u060c \u062f\u0643\u062a\u0648\u0631\u0627\u0647 \u0641\u064a \u0627\u0644\u0637\u0628\u060c \u0645\u062f\u064a\u0631 \u0623\u0628\u062d\u0627\u062b \u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0639\u064a\u0646 \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u0645\u0634\u0627\u0631\u0643 \u0644\u062e\u062f\u0645\u0629 \u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0639\u064a\u0646 \u0641\u064a \u0645\u0633\u062a\u0634\u0641\u0649 \u0648\u064a\u0644\u0632 \u0644\u0644\u0639\u064a\u0648\u0646.<\/p>\n<p>\u0643\u0627\u0646 MCO-010 \u062c\u064a\u062f \u0627\u0644\u062a\u062d\u0645\u0644 \u0628\u0634\u0643\u0644 \u0639\u0627\u0645 \u0648\u0644\u0645 \u064a\u062a\u0645 \u0627\u0644\u0625\u0628\u0644\u0627\u063a \u0639\u0646 \u0623\u064a \u0623\u062d\u062f\u0627\u062b \u0633\u0644\u0628\u064a\u0629 \u062e\u0637\u064a\u0631\u0629 \u0623\u0648 \u0634\u062f\u064a\u062f\u0629 \u0645\u0631\u062a\u0628\u0637\u0629 \u0628\u0627\u0644\u0639\u0644\u0627\u062c\u060c \u0628\u0645\u0627 \u064a\u062a\u0648\u0627\u0641\u0642 \u0645\u0639 \u0627\u0644\u062f\u0631\u0627\u0633\u0627\u062a \u0627\u0644\u0633\u0627\u0628\u0642\u0629. \u0643\u0627\u0646\u062a \u0627\u0644\u0623\u062d\u062f\u0627\u062b \u0627\u0644\u0636\u0627\u0626\u0631\u0629 \u0627\u0644\u0623\u0643\u062b\u0631 \u0634\u064a\u0648\u0639\u064b\u0627 \u0647\u064a \u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u063a\u0631\u0641\u0629 \u0627\u0644\u0623\u0645\u0627\u0645\u064a\u0629 \u0627\u0644\u062e\u0641\u064a\u0641\u0629 \u0623\u0648 \u0627\u0644\u0645\u0639\u062a\u062f\u0644\u0629 \u0648\u0627\u0631\u062a\u0641\u0627\u0639 \u0636\u063a\u0637 \u0627\u0644\u062f\u0645 \u0641\u064a \u0627\u0644\u0639\u064a\u0646. \u0644\u0645 \u064a\u062a\u0645 \u0627\u0644\u0625\u0628\u0644\u0627\u063a \u0639\u0646 \u0623\u064a \u0623\u062d\u062f\u0627\u062b \u0633\u0644\u0628\u064a\u0629 \u0630\u0627\u062a \u0623\u0647\u0645\u064a\u0629 \u062e\u0627\u0635\u0629 \u062a\u062a\u0639\u0644\u0642 \u0628\u0627\u0644\u062a\u0647\u0627\u0628 \u062f\u0627\u062e\u0644 \u0627\u0644\u0639\u064a\u0646\u060c \u0645\u062b\u0644 \u0627\u0644\u062a\u0647\u0627\u0628 \u0628\u0627\u0637\u0646 \u0627\u0644\u0645\u0642\u0644\u0629\u060c \u0623\u0648 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629\u060c \u0623\u0648 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0623\u0648\u0639\u064a\u0629 \u0627\u0644\u062f\u0645\u0648\u064a\u0629 \u0641\u064a \u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0639\u064a\u0646\u060c \u0623\u0648 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0623\u0648\u0639\u064a\u0629 \u0627\u0644\u062f\u0645\u0648\u064a\u0629 \u0627\u0644\u0627\u0646\u0633\u062f\u0627\u062f\u064a \u0641\u064a \u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0639\u064a\u0646\u060c \u0623\u0648 \u0646\u0642\u0635 \u0627\u0644\u062a\u0648\u062a\u0631\u060c \u0641\u064a \u0645\u062c\u0645\u0648\u0639\u0627\u062a \u0627\u0644\u0639\u0644\u0627\u062c.<\/p>\n<p>\u201c&quot;\u0644\u0642\u062f \u0644\u0627\u062d\u0638\u0646\u0627 \u062a\u062d\u0633\u0646\u0627\u064b \u0645\u0644\u062d\u0648\u0638\u0627\u064b \u0641\u064a \u0627\u0644\u0631\u0624\u064a\u0629 \u0644\u062f\u0649 \u0627\u0644\u0639\u062f\u064a\u062f \u0645\u0646 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631\u060c \u0628\u0645\u0646 \u0641\u064a\u0647\u0645 \u0623\u0648\u0644\u0626\u0643 \u0627\u0644\u0630\u064a\u0646 \u0643\u0627\u0646\u0648\u0627 \u0645\u0643\u0641\u0648\u0641\u064a\u0646 \u062a\u0645\u0627\u0645\u0627\u064b&quot;\u060c \u0643\u0645\u0627 \u0642\u0627\u0644.\u00a0<span class=\"xn-person\">\u062f\u064a\u0641\u064a\u062f \u0628\u0648\u064a\u0631<\/span>\u060c \u062f\u0643\u062a\u0648\u0631\u0627\u0647 \u0641\u064a \u0627\u0644\u0637\u0628 \u0645\u062d\u0642\u0642 \u0641\u064a \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0648\u0623\u0633\u062a\u0627\u0630 \u0645\u0633\u0627\u0639\u062f \u0641\u064a \u0637\u0628 \u0627\u0644\u0639\u064a\u0648\u0646 \u0627\u0644\u0633\u0631\u064a\u0631\u064a \u0641\u064a\u00a0<span class=\"xn-org\">\u062c\u0627\u0645\u0639\u0629 \u062c\u0646\u0648\u0628 \u0643\u0627\u0644\u064a\u0641\u0648\u0631\u0646\u064a\u0627<\/span>\u00a0\u0643\u0644\u064a\u0629 \u0643\u064a\u0643 \u0644\u0644\u0637\u0628. &quot;\u0644\u0642\u062f \u062d\u0642\u0642 \u0627\u0644\u0639\u062f\u064a\u062f \u0645\u0646 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u0639\u0648\u0644\u062c\u0648\u0627 \u0628\u062f\u0648\u0627\u0621 MCO-010 \u0641\u0627\u0626\u062f\u0629 \u0633\u0631\u064a\u0631\u064a\u0629 \u0645\u0644\u0645\u0648\u0633\u0629 \u0642\u0627\u0628\u0644\u0629 \u0644\u0644\u0642\u064a\u0627\u0633 \u0641\u064a \u0627\u062e\u062a\u0628\u0627\u0631 \u0648\u0638\u0627\u0626\u0641 \u0627\u0644\u0625\u0628\u0635\u0627\u0631 \u0627\u0644\u0623\u0633\u0627\u0633\u064a\u060c \u0648\u0642\u062f \u062a\u0623\u0643\u062f \u0647\u0630\u0627 \u0627\u0644\u062a\u0623\u062b\u064a\u0631 \u0645\u0646 \u062e\u0644\u0627\u0644 \u062a\u062d\u0633\u0646 \u0645\u0648\u0627\u0632\u064d \u0641\u064a \u062a\u0642\u064a\u064a\u0645\u0627\u062a \u0627\u0644\u0631\u0624\u064a\u0629 \u0627\u0644\u0648\u0638\u064a\u0641\u064a\u0629. \u0641\u064a \u062d\u0627\u0644 \u0627\u0644\u0645\u0648\u0627\u0641\u0642\u0629 \u0639\u0644\u064a\u0647\u060c \u0645\u0646 \u0627\u0644\u0645\u062a\u0648\u0642\u0639 \u0623\u0646 \u064a\u064f\u062d\u062f\u062b \u062f\u0648\u0627\u0621 MCO-010 \u0623\u062b\u0631\u064b\u0627 \u0625\u064a\u062c\u0627\u0628\u064a\u064b\u0627 \u0648\u0645\u0644\u0645\u0648\u0633\u064b\u0627 \u0641\u064a \u062d\u064a\u0627\u0629 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0647\u0630\u0647 \u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u0645\u0646\u0647\u0643\u0629.&quot;\u201c<\/p>\n<p>\u0648\u0628\u0646\u0627\u0621\u064b \u0639\u0644\u0649 \u0647\u0630\u0647 \u0627\u0644\u0646\u062a\u0627\u0626\u062c\u060c \u062a\u0639\u062a\u0632\u0645 \u0634\u0631\u0643\u0629 Nanscope \u062a\u0642\u062f\u064a\u0645 BLA \u0625\u0644\u0649 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0641\u064a \u0627\u0644\u0646\u0635\u0641 \u0627\u0644\u062b\u0627\u0646\u064a \u0645\u0646 \u0639\u0627\u0645 2024 \u0643\u062e\u0637\u0648\u0629 \u0623\u0648\u0644\u0649 \u0641\u064a \u062a\u0646\u0641\u064a\u0630 \u0627\u0633\u062a\u0631\u0627\u062a\u064a\u062c\u064a\u062a\u0647\u0627 \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629 \u0648\u0627\u0644\u062a\u0633\u0648\u064a\u0642\u064a\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064a\u0629.<\/p>\n<p>\u201c&quot;\u0623\u0646\u0627 \u0633\u0639\u064a\u062f \u0644\u0644\u063a\u0627\u064a\u0629 \u0644\u0631\u0624\u064a\u0629 \u0623\u0646 MCO-010 \u0644\u062f\u064a\u0647 \u0627\u0644\u0642\u062f\u0631\u0629 \u0639\u0644\u0649 \u062a\u062d\u0633\u064a\u0646 \u0627\u0644\u0631\u0624\u064a\u0629 \u0644\u062f\u0649 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0645\u0631\u0636 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a \u0627\u0644\u0645\u062a\u0642\u062f\u0645&quot;\u060c \u0642\u0627\u0644\u00a0<span class=\"xn-person\">\u0623\u0631\u0634\u062f \u0645. \u062e\u0627\u0646\u0627\u0646\u064a<\/span>\u060c \u062f\u0643\u062a\u0648\u0631\u0627\u0647 \u0641\u064a \u0627\u0644\u0637\u0628\u060c \u0645\u0627\u062c\u0633\u062a\u064a\u0631\u060c FASRS\u060c \u0645\u062f\u064a\u0631 \u0627\u0644\u0623\u0628\u062d\u0627\u062b \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0641\u064a Sierra Eye Associates \u0648\u0623\u0633\u062a\u0627\u0630 \u0633\u0631\u064a\u0631\u064a \u0641\u064a\u00a0<span class=\"xn-org\">\u062c\u0627\u0645\u0639\u0629 \u0646\u064a\u0641\u0627\u062f\u0627\u060c \u0631\u064a\u0646\u0648<\/span>\u00a0\u0643\u0644\u064a\u0629 \u0627\u0644\u0637\u0628. &quot;\u0647\u0630\u0647 \u0644\u062d\u0638\u0629 \u0645\u062d\u0648\u0631\u064a\u0629 \u0641\u064a \u0645\u062c\u0627\u0644 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u0644\u0644\u0639\u064a\u0646\u060c \u062d\u064a\u062b \u064a\u0648\u062c\u062f \u0639\u0644\u0627\u062c \u0645\u062d\u062a\u0645\u0644 \u062f\u0627\u062e\u0644 \u0627\u0644\u062c\u0633\u0645 \u0627\u0644\u0632\u062c\u0627\u062c\u064a \u0644\u0627 \u064a\u0639\u062a\u0645\u062f \u0639\u0644\u0649 \u0627\u0644\u0637\u0641\u0631\u0627\u062a \u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a\u060c \u0648\u0647\u0648 \u0645\u0631\u0636 \u0644\u0627 \u064a\u0648\u062c\u062f \u0644\u0647 \u0639\u0644\u0627\u062c \u0645\u062a\u0627\u062d \u062d\u0627\u0644\u064a\u064b\u0627 \u0648\u064a\u0624\u062f\u064a \u0625\u0644\u0649 \u0641\u0642\u062f\u0627\u0646 \u0627\u0644\u0628\u0635\u0631 \u0627\u0644\u062f\u0627\u0626\u0645.&quot;\u201c<\/p>\n<p>\u201c&quot;\u062a\u062a\u0628\u0648\u0623 \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u0645\u0643\u0627\u0646\u0629 \u0631\u0627\u0626\u062f\u0629 \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629 \u0644\u064a\u0635\u0628\u062d \u062d\u0644\u0627\u064b \u0639\u0644\u0627\u062c\u064a\u0627\u064b \u0645\u0644\u0645\u0648\u0633\u0627\u064b \u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a&quot;\u060c \u0643\u0645\u0627 \u0635\u0631\u062d\u062a \u0627\u0644\u0634\u0631\u0643\u0629.\u00a0<span class=\"xn-person\">\u0633\u0648\u0644\u0627\u062c\u0646\u0627 \u0628\u0647\u0627\u062a\u0627\u0634\u0627\u0631\u064a\u0627<\/span>, \u060c \u0627\u0644\u0645\u0624\u0633\u0633 \u0627\u0644\u0645\u0634\u0627\u0631\u0643 \u0648\u0627\u0644\u0631\u0626\u064a\u0633 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a \u0644\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628. &quot;\u062a\u064f\u0642\u062f\u0651\u0645 \u0627\u0644\u0628\u064a\u0627\u0646\u0627\u062a \u0627\u0644\u0645\u0642\u0646\u0639\u0629 \u0645\u0646 \u0623\u062d\u062f\u062b \u062a\u062d\u0644\u064a\u0644\u0627\u062a \u062a\u062c\u0631\u0628\u0629 RESTORE \u0641\u064a \u0627\u0644\u0623\u0633\u0628\u0648\u0639 76 \u062a\u0623\u0643\u064a\u062f\u064b\u0627 \u0625\u0636\u0627\u0641\u064a\u064b\u0627 \u0644\u0645\u0646\u0635\u0629 MCO \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645\u0627\u062a \u0645\u0646 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u064f\u0633\u0647\u0645 \u0641\u064a \u062a\u0648\u0633\u064a\u0639 \u0646\u0637\u0627\u0642 \u0628\u0631\u0627\u0645\u062c\u0646\u0627 \u0644\u0639\u0644\u0627\u062c \u0643\u0644\u064d \u0645\u0646 \u0645\u0631\u0636 \u0633\u062a\u0627\u0631\u063a\u0627\u0631\u062f\u062a \u0648\u0627\u0644\u0636\u0645\u0648\u0631 \u0627\u0644\u062c\u063a\u0631\u0627\u0641\u064a \u0627\u0644\u0646\u0627\u062a\u062c \u0639\u0646 \u0627\u0644\u062a\u0646\u0643\u0633 \u0627\u0644\u0628\u0642\u0639\u064a \u0627\u0644\u0645\u0631\u062a\u0628\u0637 \u0628\u0627\u0644\u0639\u0645\u0631. \u0646\u064f\u0639\u0631\u0628 \u0639\u0646 \u062e\u0627\u0644\u0635 \u062a\u0642\u062f\u064a\u0631\u0646\u0627 \u0644\u0644\u0645\u0634\u0627\u0631\u0643\u064a\u0646 \u0641\u064a \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0648\u0639\u0627\u0626\u0644\u0627\u062a\u0647\u0645\u060c \u0648\u0643\u0630\u0644\u0643 \u0644\u0644\u0645\u062d\u0642\u0642\u064a\u0646 \u0648\u062c\u0645\u064a\u0639 \u0645\u0646 \u0633\u0627\u0647\u0645\u0648\u0627 \u0641\u064a \u0647\u0630\u0647 \u0627\u0644\u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0631\u0627\u0626\u062f\u0629 \u0648\u0625\u062a\u0645\u0627\u0645\u0647\u0627 \u0628\u0646\u062c\u0627\u062d.&quot;\u201c<\/p>\n<p>\u062a\u0645\u062b\u0644 \u0647\u0630\u0647 \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0623\u0648\u0644 \u062f\u0644\u064a\u0644 \u0639\u0644\u0649 \u0641\u0639\u0627\u0644\u064a\u0629 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u0627\u0644\u0644\u0627\u0625\u0631\u0627\u062f\u064a \u0644\u0644\u0637\u0641\u0631\u0629 \u0644\u0645\u0631\u0636 \u0648\u0631\u0627\u062b\u064a. \u062a\u0639\u0643\u0633 \u0647\u0630\u0647 \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0623\u0643\u062b\u0631 \u0645\u0646 \u0639\u0642\u062f \u0645\u0646 \u0627\u0644\u0627\u0628\u062a\u0643\u0627\u0631 \u0641\u064a \u062c\u0645\u064a\u0639 \u062c\u0648\u0627\u0646\u0628 \u0628\u0631\u0646\u0627\u0645\u062c MCO-010\u060c \u0628\u0645\u0627 \u0641\u064a \u0630\u0644\u0643 \u062a\u0635\u0645\u064a\u0645 \u0627\u0644\u0645\u062a\u062c\u0647\u0627\u062a \u0648\u0627\u0644\u062a\u0635\u0646\u064a\u0639 \u0648\u062a\u0635\u0645\u064a\u0645 \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629\u060c \u0628\u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0625\u0644\u0649 \u062a\u0637\u0648\u064a\u0631 \u0646\u0642\u0627\u0637 \u0646\u0647\u0627\u064a\u0629 \u0631\u0624\u064a\u0629 \u0648\u0638\u064a\u0641\u064a\u0629 \u062c\u062f\u064a\u062f\u0629 \u0644\u0647\u0624\u0644\u0627\u0621 \u0627\u0644\u0633\u0643\u0627\u0646 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0627\u0644\u0628\u0635\u0631 \u0627\u0644\u0634\u062f\u064a\u062f.<\/p>\n<p>\u201c&quot;\u062a\u0645\u062b\u0644 \u0647\u0630\u0647 \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u062a\u062a\u0648\u064a\u062c\u064b\u0627 \u0644\u0623\u0643\u062b\u0631 \u0645\u0646 \u0639\u0642\u062f \u0645\u0646 \u0627\u0644\u0639\u0645\u0644 \u0645\u0646 \u0642\u0628\u0644 \u0627\u0644\u0639\u062f\u064a\u062f \u0645\u0646 \u0627\u0644\u0623\u0641\u0631\u0627\u062f \u0627\u0644\u0645\u062a\u0641\u0627\u0646\u064a\u0646\u060c \u0645\u0645\u0627 \u064a\u0624\u0643\u062f \u0625\u0645\u0643\u0627\u0646\u0627\u062a \u0645\u0646\u0635\u0629 MCO-010 \u0627\u0644\u0641\u0631\u064a\u062f\u0629 \u0630\u0627\u062a \u0627\u0644\u0646\u0637\u0627\u0642 \u0627\u0644\u0639\u0631\u064a\u0636 \u0648\u0627\u0644\u062d\u0633\u0627\u0633\u064a\u0629 \u0627\u0644\u0636\u0648\u0626\u064a\u0629 \u0627\u0644\u0639\u0627\u0644\u064a\u0629 \u0648\u0627\u0644\u0633\u0631\u0639\u0629 \u0627\u0644\u0639\u0627\u0644\u064a\u0629&quot;\u060c\u00a0<span class=\"xn-person\">\u0633\u0627\u0645\u0627\u0631\u0646\u062f\u0631\u0627 \u0645\u0648\u0647\u0627\u0646\u062a\u064a<\/span>, \u062d\u0627\u0635\u0644 \u0639\u0644\u0649 \u062f\u0631\u062c\u0629 \u0627\u0644\u062f\u0643\u062a\u0648\u0631\u0627\u0647\u060c \u0627\u0644\u0645\u0624\u0633\u0633 \u0627\u0644\u0645\u0634\u0627\u0631\u0643 \u0648\u0627\u0644\u0631\u0626\u064a\u0633 \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u0639\u0644\u0645\u064a \u0644\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628. &quot;\u064a\u0645\u062b\u0644 \u0647\u0630\u0627 \u0627\u0644\u0625\u0646\u062c\u0627\u0632 \u0639\u0644\u0627\u0645\u0629 \u0641\u0627\u0631\u0642\u0629 \u0641\u064a \u0645\u062c\u0627\u0644 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a \u063a\u064a\u0631 \u0627\u0644\u0645\u0631\u062a\u0628\u0637 \u0628\u0646\u0648\u0639 \u0627\u0644\u0637\u0641\u0631\u0629\u060c \u0645\u0645\u0627 \u064a\u0631\u0633\u062e \u0628\u0642\u0648\u0629 \u0625\u0645\u0643\u0627\u0646\u0627\u062a \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629 \u0643\u0637\u0631\u064a\u0642\u0629 \u0639\u0644\u0627\u062c\u064a\u0629 \u0648\u0627\u0639\u062f\u0629. \u0646\u062a\u0642\u062f\u0645 \u0628\u062c\u0632\u064a\u0644 \u0627\u0644\u0634\u0643\u0631 \u0644\u0644\u0645\u0639\u0647\u062f \u0627\u0644\u0648\u0637\u0646\u064a \u0644\u0644\u0639\u064a\u0648\u0646 \u0627\u0644\u062a\u0627\u0628\u0639 \u0644\u0644\u0645\u0639\u0627\u0647\u062f \u0627\u0644\u0648\u0637\u0646\u064a\u0629 \u0644\u0644\u0635\u062d\u0629 \u0648\u0634\u0631\u0643\u0627\u0626\u0647 \u0639\u0644\u0649 \u0645\u0633\u0627\u0647\u0645\u0627\u062a\u0647\u0645 \u0627\u0644\u0642\u064a\u0651\u0645\u0629 \u0641\u064a \u062a\u062d\u0642\u064a\u0642 \u0627\u0644\u0625\u0645\u0643\u0627\u0646\u0627\u062a \u0627\u0644\u0639\u0644\u0627\u062c\u064a\u0629 \u0644\u0639\u0644\u0627\u062c MCO\u060c \u0645\u0645\u0627 \u064a\u0645\u0646\u062d \u0627\u0644\u0623\u0645\u0644 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0644\u0645\u0631\u0636\u0649 \u0628\u063a\u0636 \u0627\u0644\u0646\u0638\u0631 \u0639\u0646 \u0637\u0641\u0631\u062a\u0647\u0645 \u0627\u0644\u062c\u064a\u0646\u064a\u0629 \u0627\u0644\u0623\u0633\u0627\u0633\u064a\u0629.&quot;\u201c<\/p>\n<p><b>\u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u062a\u0641\u0627\u0635\u064a\u0644 \u0627\u0644\u062a\u062c\u0631\u064a\u0628\u064a\u0629<br class=\"dnr\" \/><\/b>\u0645\u062a\u0639\u062f\u062f \u0627\u0644\u0645\u0631\u0627\u0643\u0632\u060c \u0627\u0644\u0645\u0631\u062d\u0644\u0629\u00a0<span class=\"xn-money\">2\u0628<\/span>\u00a0\u062a\u0645 \u0627\u062e\u062a\u064a\u0627\u0631 28 \u0634\u062e\u0635\u064b\u0627 \u0628\u0634\u0643\u0644 \u0639\u0634\u0648\u0627\u0626\u064a \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0627\u0644\u0628\u0635\u0631 \u0627\u0644\u0634\u062f\u064a\u062f \u0648\u0627\u0644\u062a\u0634\u062e\u064a\u0635 \u0627\u0644\u0633\u0631\u064a\u0631\u064a \u0627\u0644\u0645\u0624\u0643\u062f \u0644\u0645\u0631\u0636 RP. \u0644\u0645 \u064a\u062a\u0645 \u062a\u0636\u0645\u064a\u0646 \u0645\u0648\u0636\u0648\u0639 \u0648\u0627\u062d\u062f \u0639\u0634\u0648\u0627\u0626\u064a\u060c \u0627\u0644\u0630\u064a \u0633\u062d\u0628 \u0645\u0648\u0627\u0641\u0642\u062a\u0647 \u0642\u0628\u0644 \u0642\u064a\u0627\u0633\u0627\u062a \u062e\u0637 \u0627\u0644\u0623\u0633\u0627\u0633 \u0648\u062a\u062f\u062e\u0644 \u0627\u0644\u062f\u0631\u0627\u0633\u0629\u060c \u0641\u064a \u0645\u062c\u062a\u0645\u0639 mITT. \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0627\u0644\u0645\u0628\u0644\u063a \u0639\u0646\u0647\u0627 \u0645\u0623\u062e\u0648\u0630\u0629 \u0645\u0646 \u0645\u062c\u062a\u0645\u0639 mITT \u0627\u0644\u0630\u064a \u0634\u0645\u0644 \u062c\u0645\u064a\u0639 \u0627\u0644\u0623\u0634\u062e\u0627\u0635 \u0627\u0644\u0639\u0634\u0648\u0627\u0626\u064a\u064a\u0646 \u0627\u0644\u0630\u064a\u0646 \u062a\u0644\u0642\u0648\u0627 \u0627\u0644\u062a\u062f\u062e\u0644 \u0641\u064a \u0639\u064a\u0646 \u0627\u0644\u062f\u0631\u0627\u0633\u0629 (MCO-010 \u0623\u0648 \u0627\u0644\u062a\u062d\u0643\u0645): 18 \u0634\u062e\u0635\u064b\u0627 \u0641\u064a \u0645\u062c\u0645\u0648\u0639\u0627\u062a MCO-010 \u0648 9 \u0623\u0634\u062e\u0627\u0635 \u0641\u064a \u0627\u0644\u0645\u062c\u0645\u0648\u0639\u0629 \u0627\u0644\u0636\u0627\u0628\u0637\u0629. \u0628\u0627\u0644\u0646\u0633\u0628\u0629 \u0644\u0646\u0642\u0627\u0637 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u064a\u0629 \u0648\u0627\u0644\u062b\u0627\u0646\u0648\u064a\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\u060c \u062a\u0645 \u062a\u0642\u064a\u064a\u0645 \u0627\u0644\u0645\u0648\u0636\u0648\u0639\u0627\u062a \u0641\u064a \u0646\u0642\u0627\u0637 \u0632\u0645\u0646\u064a\u0629 \u0645\u062a\u0639\u062f\u062f\u0629 \u0639\u0644\u0649 \u0645\u062f\u0627\u0631 \u0639\u0627\u0645\u064a\u0646 \u0644\u062a\u0642\u064a\u064a\u0645 BCVA\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u0645 \u0642\u064a\u0627\u0633\u0647\u0627 \u0628\u0648\u0627\u0633\u0637\u0629 \u0627\u062e\u062a\u0628\u0627\u0631 \u0641\u0631\u0627\u064a\u0628\u0648\u0631\u063a \u0644\u062d\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.<\/p>\n<ul type=\"disc\">\n<li>\u062a\u0645 \u0625\u062c\u0631\u0627\u0621 \u0646\u0645\u0648\u0630\u062c \u062e\u0637\u064a \u0645\u062e\u062a\u0644\u0637 \u0627\u0644\u062a\u0623\u062b\u064a\u0631\u0627\u062a \u0644\u0644\u062a\u062f\u0627\u0628\u064a\u0631 \u0627\u0644\u0645\u062a\u0643\u0631\u0631\u0629 (MMRM) \u0639\u0644\u0649 \u0646\u0642\u0627\u0637 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u062b\u0627\u0646\u0648\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u064a\u0629 \u0648\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\u060c \u062d\u064a\u062b \u062a\u0645 \u062a\u0636\u0645\u064a\u0646 \u0628\u064a\u0627\u0646\u0627\u062a \u062d\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0645\u0646 \u062c\u0645\u064a\u0639 \u0632\u064a\u0627\u0631\u0627\u062a \u0645\u0627 \u0628\u0639\u062f \u062e\u0637 \u0627\u0644\u0623\u0633\u0627\u0633 \u0641\u064a \u0627\u0644\u0646\u0645\u0648\u0630\u062c\u060c \u0645\u0639 \u062d\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0627\u0644\u0623\u0633\u0627\u0633\u064a\u0629 \u0643\u0645\u062a\u063a\u064a\u0631 \u0645\u0634\u062a\u0631\u0643.<\/li>\n<li>\u0648\u0623\u062c\u0631\u064a\u062a \u0645\u0642\u0627\u0631\u0646\u0627\u062a \u0628\u064a\u0646 \u0645\u062c\u0645\u0648\u0639\u0627\u062a \u0627\u0644\u0639\u0644\u0627\u062c \u0628\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0625\u062c\u0631\u0627\u0621 Hochberg \u0644\u0636\u0628\u0637 \u0645\u0642\u0627\u0631\u0646\u0627\u062a \u0645\u062a\u0639\u062f\u062f\u0629 \u0636\u062f \u0627\u0644\u0633\u064a\u0637\u0631\u0629. \u0628\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0646\u062a\u0627\u0626\u062c \u0627\u0644\u062a\u064a \u062a\u0645 \u0627\u0644\u062d\u0635\u0648\u0644 \u0639\u0644\u064a\u0647\u0627 \u0645\u0646 \u0646\u0645\u0648\u0630\u062c MMRM\u060c\u00a0<i>\u0639-<\/i>\u062a\u0645 \u062a\u0631\u062a\u064a\u0628 \u0627\u0644\u0642\u064a\u0645 \u0645\u0646 \u0627\u0644\u0645\u0642\u0627\u0631\u0646\u062a\u064a\u0646 \u0644\u0645\u062c\u0645\u0648\u0639\u0627\u062a MCO-010 \u0645\u0642\u0627\u0628\u0644 \u0639\u0646\u0635\u0631 \u0627\u0644\u062a\u062d\u0643\u0645 \u0645\u0646 \u0627\u0644\u0623\u0643\u0628\u0631 \u0625\u0644\u0649 \u0627\u0644\u0623\u0635\u063a\u0631.<\/li>\n<li>\u062a\u0639\u062a\u0645\u062f \u0646\u062a\u0627\u0626\u062c \u0646\u0642\u0637\u0629 \u0646\u0647\u0627\u064a\u0629 \u062d\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0627\u0644\u0623\u0648\u0644\u064a\u0629 \u0648\u0627\u0644\u062b\u0627\u0646\u0648\u064a\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629 \u0627\u0644\u062a\u064a \u064a\u062a\u0645 \u0627\u0644\u0625\u0628\u0644\u0627\u063a \u0639\u0646\u0647\u0627 \u0639\u0644\u0649 \u0627\u0644\u0645\u0646\u0627\u0642\u0634\u0627\u062a \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629\u060c\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4123320-1&h=1781377654&u=https%3A%2F%2Fnanostherapeutics.com%2F2024%2F01%2F18%2Fnanoscope-therapeutics-provides-regulatory-update-on-mco-010-for-the-treatment-of-retinitis-pigmentosa%2F&a=as+previously+announced+on+January+18%2C+2024\" target=\"_blank\" rel=\"nofollow noopener\">\u0643\u0645\u0627 \u0623\u0639\u0644\u0646 \u0633\u0627\u0628\u0642\u0627 \u0639\u0644\u0649\u00a0<span class=\"xn-chron\">18 \u064a\u0646\u0627\u064a\u0631 2024<\/span><\/a>\u060c \u0648\u0645\u0648\u0627\u0621\u0645\u0629 \u0646\u0642\u0627\u0637 \u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u062f\u0631\u0627\u0633\u0629 \u0645\u0639 \u0623\u0647\u062f\u0627\u0641 \u0627\u0644\u062f\u0631\u0627\u0633\u0629 \u0627\u0644\u0645\u0642\u0635\u0648\u062f\u0629 \u0623\u0635\u0644\u0627\u064b. \u062a\u0645 \u0627\u0644\u0627\u0646\u062a\u0647\u0627\u0621 \u0645\u0646 \u062e\u0637\u0629 \u0627\u0644\u062a\u062d\u0644\u064a\u0644 \u0627\u0644\u0625\u062d\u0635\u0627\u0626\u064a \u0627\u0644\u0645\u0646\u0642\u062d\u0629 (SAP) \u0648\u062a\u0642\u062f\u064a\u0645\u0647\u0627 \u0625\u0644\u0649 \u0627\u0644\u0645\u0646\u0638\u0645\u064a\u0646 \u0642\u0628\u0644 \u0627\u0644\u0627\u0646\u062a\u0647\u0627\u0621 \u0645\u0646 \u0627\u0644\u0623\u0633\u0628\u0648\u0639 76 \u0648\u0627\u0644\u0646\u0642\u0627\u0637 \u0627\u0644\u0632\u0645\u0646\u064a\u0629 \u0627\u0644\u0644\u0627\u062d\u0642\u0629 \u0644\u0644\u062f\u0631\u0627\u0633\u0629.<\/li>\n<li>\u062a\u0645 \u062a\u0642\u064a\u064a\u0645 \u0627\u0644\u0631\u0624\u064a\u0629 \u0627\u0644\u0648\u0638\u064a\u0641\u064a\u0629 \u0645\u0646 \u062e\u0644\u0627\u0644 \u062a\u0642\u064a\u064a\u0645 \u0623\u062f\u0627\u0621 \u0627\u0644\u0645\u0648\u0636\u0648\u0639 \u0641\u064a \u0627\u0644\u062a\u0639\u0631\u0641 \u0639\u0644\u0649 \u0627\u0644\u0623\u0634\u064a\u0627\u0621 \u0623\u0648 \u0627\u0644\u062a\u0646\u0642\u0644 \u0641\u064a \u062f\u0648\u0631\u0629 \u0627\u0644\u062a\u0646\u0642\u0644 \u0641\u064a \u0638\u0644 \u0645\u062c\u0645\u0648\u0639\u0629 \u0645\u062a\u0646\u0648\u0639\u0629 \u0645\u0646 \u0645\u0633\u062a\u0648\u064a\u0627\u062a \u0627\u0644\u0625\u0636\u0627\u0621\u0629 \u0627\u0644\u062a\u064a \u062a\u0645\u062a \u0645\u0648\u0627\u062c\u0647\u062a\u0647\u0627 \u0641\u064a \u0623\u0646\u0634\u0637\u0629 \u0627\u0644\u062d\u064a\u0627\u0629 \u0627\u0644\u064a\u0648\u0645\u064a\u0629.<\/li>\n<\/ul>\n<p>\u0641\u064a\u0645\u0627 \u064a\u0644\u064a \u0645\u0644\u062e\u0635 \u0644\u0646\u062a\u0627\u0626\u062c \u0641\u0639\u0627\u0644\u064a\u0629 \u0627\u0644\u062e\u0637 \u0627\u0644\u0639\u0644\u0648\u064a:<\/p>\n<div>\n<div class=\"divOverflow\">\n<div class=\"table-responsive\">\n<table class=\"prnbcc\" border=\"0\" width=\"\" cellspacing=\"0\" cellpadding=\"1\">\n<tbody>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"2\" width=\"\" height=\"\"><\/td>\n<td class=\"prngen2\" colspan=\"2\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><b><i>\u0646\u0642\u0637\u0629 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u064a\u0629:<\/i><\/b><i>\u00a0BCVA \u0641\u064a \u0627\u0644\u0623\u0633\u0628\u0648\u0639 52<\/i><\/span><\/p>\n<\/td>\n<td class=\"prnpr2 prnpl2 prnvab prncbts prnbrbrs prnbbbs prnsblb1\" colspan=\"2\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><b><i>\u0646\u0642\u0637\u0629 \u0627\u0644\u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u062b\u0627\u0646\u0648\u064a\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629:<\/i><\/b><i>\u00a0BCVA \u0641\u064a \u0627\u0644\u0623\u0633\u0628\u0648\u0639 76<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>\u0627\u0644\u062a\u063a\u064a\u064a\u0631 \u0641\u064a LogMAR \u0645\u0646<br class=\"dnr\" \/>\u062e\u0637 \u0627\u0644\u0623\u0633\u0627\u0633 (\u064a\u0639\u0646\u064a \u00b1 SEM)<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>\u0642\u064a\u0645\u0629 P<\/i><\/span><\/p>\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>\u0645\u0642\u0627\u0628\u0644 \u0627\u0644\u062a\u062d\u0643\u0645<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>\u0627\u0644\u062a\u063a\u064a\u064a\u0631 \u0641\u064a LogMAR \u0645\u0646<br class=\"dnr\" \/>\u062e\u0637 \u0627\u0644\u0623\u0633\u0627\u0633 (\u064a\u0639\u0646\u064a \u00b1 SEM)<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>\u0642\u064a\u0645\u0629 P<\/i><\/span><\/p>\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>\u0645\u0642\u0627\u0628\u0644 \u0627\u0644\u062a\u062d\u0643\u0645<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><b><i>\u062c\u0631\u0639\u0629 \u0639\u0627\u0644\u064a\u0629 \u0645\u0646 MCO-010<\/i><\/b><\/span><\/p>\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><b><i>(1.2E11 \u062c\u064a \u0633\u064a\u060c \u0646 = 9)<\/i><\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>-0.337 \u00b10.0829<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>0.0209<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>-0.539 \u00b1 0.1032<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>0.0014<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><b><i>\u062c\u0631\u0639\u0629 \u0645\u0646\u062e\u0641\u0636\u0629 MCO-010<\/i><\/b><\/span><\/p>\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><b><i>(0.9E11 \u062c\u064a \u0633\u064a\u060c \u0646 = 9)<\/i><\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>-0.382 \u00b10.1244<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>0.0290<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>-0.374 \u00b1 0.1332<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>0.0652<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><b><i>\u0627\u0644\u0633\u064a\u0637\u0631\u0629 \u0627\u0644\u0634\u0627\u0645\u064a\u0629<\/i><\/b><\/span><\/p>\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><b><i>(\u0646 = 9)<\/i><\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>-0.050 \u00b10.0717<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>\u2014-<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>-0.078 \u00b1 0.0737<\/i><\/span><\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\" width=\"\" height=\"\">\n<p class=\"prnml4 dnr\"><span class=\"prnews_span\"><i>\u2014-<\/i><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><b>\u062d\u0648\u0644 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a<br class=\"dnr\" \/><\/b>\u064a\u0634\u0645\u0644 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a \u0645\u062c\u0645\u0648\u0639\u0629 \u0645\u0646 \u0627\u0644\u0627\u0636\u0637\u0631\u0627\u0628\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629 \u0627\u0644\u0646\u0627\u062f\u0631\u0629 \u0627\u0644\u062a\u064a \u062a\u062a\u062f\u0647\u0648\u0631 \u0641\u064a\u0647\u0627 \u062e\u0644\u0627\u064a\u0627 \u0645\u0633\u062a\u0642\u0628\u0644\u0627\u062a \u0627\u0644\u0636\u0648\u0621 \u0641\u064a \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0645\u0639 \u0645\u0631\u0648\u0631 \u0627\u0644\u0648\u0642\u062a\u060c \u0645\u0645\u0627 \u064a\u0624\u062f\u064a \u0625\u0644\u0649 \u0636\u0639\u0641 \u0627\u0644\u0628\u0635\u0631 \u0648\u0627\u0644\u0639\u0645\u0649 \u0641\u064a \u0646\u0647\u0627\u064a\u0629 \u0627\u0644\u0645\u0637\u0627\u0641. \u064a\u064f\u0639\u062a\u0642\u062f \u0623\u0646 \u0647\u0630\u0647 \u0627\u0644\u0627\u0636\u0637\u0631\u0627\u0628\u0627\u062a \u0645\u0631\u062a\u0628\u0637\u0629 \u0628\u0623\u0643\u062b\u0631 \u0645\u0646 100 \u0637\u0641\u0631\u0629 \u062c\u064a\u0646\u064a\u0629 \u0645\u062e\u062a\u0644\u0641\u0629. \u064a\u0639\u0627\u0646\u064a \u0645\u0627 \u064a\u0642\u0631\u0628 \u0645\u0646 100 \u0623\u0644\u0641 \u0634\u062e\u0635 \u0641\u064a \u0627\u0644\u0648\u0644\u0627\u064a\u0627\u062a \u0627\u0644\u0645\u062a\u062d\u062f\u0629\u060c \u0648\u0645\u0627 \u064a\u0642\u062f\u0631 \u0628\u0646\u062d\u0648 \u0645\u0644\u064a\u0648\u0646\u064a \u0634\u062e\u0635 \u062d\u0648\u0644 \u0627\u0644\u0639\u0627\u0644\u0645\u060c \u0645\u0646 \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a\u060c \u0645\u0645\u0627 \u064a\u062c\u0639\u0644\u0647 \u0627\u0644\u0633\u0628\u0628 \u0627\u0644\u0631\u0626\u064a\u0633\u064a \u0644\u0644\u0639\u0645\u0649 \u0627\u0644\u0648\u0631\u0627\u062b\u064a.<\/p>\n<p><b>\u062d\u0648\u0644 MCO-010<br class=\"dnr\" \/><\/b>\u062a\u0647\u062f\u0641 \u0627\u0644\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u062c\u064a\u0646\u064a\u0629 \u0627\u0644\u062d\u0627\u0644\u064a\u0629 \u0625\u0644\u0649 \u0639\u0644\u0627\u062c \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0637\u0641\u0631\u0627\u062a \u062c\u064a\u0646\u064a\u0629 \u0645\u062d\u062f\u062f\u0629 \u0648\u062a\u0643\u0648\u0646 \u0645\u062d\u062f\u0648\u062f\u0629 \u0623\u064a\u0636\u064b\u0627 \u0641\u064a \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u062a\u0642\u062f\u0645\u0629 \u0627\u0644\u062a\u064a \u062a\u062d\u062a\u0648\u064a \u0639\u0644\u0649 \u062e\u0644\u0627\u064a\u0627 \u0634\u0628\u0643\u064a\u0629 \u062e\u0627\u0631\u062c\u064a\u0629 \u0645\u062a\u062f\u0647\u0648\u0631\u0629. \u064a\u0633\u062a\u0647\u062f\u0641 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0623\u062d\u0627\u062f\u064a \u0627\u0644\u0628\u0635\u0631\u064a MCO \u0627\u0644\u0642\u0627\u0628\u0644 \u0644\u0644\u062a\u0646\u0634\u064a\u0637 \u0628\u0627\u0644\u0636\u0648\u0621 \u0627\u0644\u0645\u062d\u064a\u0637 \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u0639\u0635\u0628\u064a\u0629 \u0627\u0644\u062f\u0627\u062e\u0644\u064a\u0629 \u0627\u0644\u0648\u0641\u064a\u0631\u0629 \u0641\u064a \u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0639\u064a\u0646 \u0648\u0644\u062f\u064a\u0647 \u0627\u0644\u0642\u062f\u0631\u0629 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0631\u0624\u064a\u0629 \u0627\u0644\u0645\u0641\u0642\u0648\u062f\u0629 \u0628\u0634\u0643\u0644 \u062f\u0627\u0626\u0645 \u0628\u0633\u0628\u0628 RP \u0627\u0644\u0645\u062a\u0642\u062f\u0645. \u0645\u0643\u0648-010 (<i>\u0633\u0648\u0646\u0628\u064a\u0631\u064a\u062a\u064a\u062c\u064a\u0646\u064a \u0625\u0633\u062a\u064a\u0628\u0627\u0631\u0641\u0648\u0641\u064a\u0643<\/i>\u060c \u062a\u0639\u0644\u064a\u0642 \u0644\u0644\u062d\u0642\u0646 \u062f\u0627\u062e\u0644 \u0627\u0644\u062c\u0633\u0645 \u0627\u0644\u0632\u062c\u0627\u062c\u064a) \u0647\u0648 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0627\u0644\u0648\u062d\u064a\u062f \u0639\u0631\u064a\u0636 \u0627\u0644\u0646\u0637\u0627\u0642 \u0648\u0627\u0644\u0633\u0631\u064a\u0639 \u0648\u0627\u0644\u062d\u0633\u0627\u0633 \u0644\u0644\u063a\u0627\u064a\u0629 \u0644\u0644\u0636\u0648\u0621 \u0627\u0644\u0645\u0648\u062c\u0648\u062f \u062d\u0627\u0644\u064a\u064b\u0627 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0645\u0646 \u062e\u0644\u0627\u0644 \u0627\u0633\u062a\u0647\u062f\u0627\u0641 \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u062b\u0646\u0627\u0626\u064a\u0629 \u0627\u0644\u0642\u0637\u0628 \u0639\u0628\u0631 \u0645\u0639\u0632\u0632 mGluR6\u060c \u062a\u0645 \u062a\u0635\u0645\u064a\u0645 \u0634\u0631\u064a\u0637 \u0627\u0644\u062a\u0639\u0628\u064a\u0631 MCO-010 \u0644\u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0631\u0624\u064a\u0629 \u0639\u0627\u0644\u064a\u0629 \u0627\u0644\u062c\u0648\u062f\u0629 \u0641\u064a \u0628\u064a\u0626\u0627\u062a \u0627\u0644\u0639\u0627\u0644\u0645 \u0627\u0644\u062d\u0642\u064a\u0642\u064a. \u064a\u0633\u0645\u062d \u0646\u0627\u0642\u0644 AAV2 \u0627\u0644\u062e\u0627\u0635 \u0628\u0627\u0644\u0646\u0642\u0644 \u0627\u0644\u0642\u0648\u064a \u0644\u0640 MCO-010 \u0641\u064a \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u062b\u0646\u0627\u0626\u064a\u0629 \u0627\u0644\u0642\u0637\u0628 \u0639\u0646\u062f \u0627\u0644\u062d\u0642\u0646 \u062f\u0627\u062e\u0644 \u0627\u0644\u062c\u0633\u0645 \u0627\u0644\u0632\u062c\u0627\u062c\u064a. \u0623\u0638\u0647\u0631\u062a \u062f\u0631\u0627\u0633\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 1\/2\u0623 \u0644\u0640 MCO-010 \u0644\u062f\u0649 \u0645\u0631\u0636\u0649 RP \u0627\u0644\u0645\u062a\u0642\u062f\u0645\u064a\u0646 \u0633\u0644\u0627\u0645\u0629 \u0645\u0648\u0627\u062a\u064a\u0629 \u0648\u062a\u062d\u0633\u0646\u064b\u0627 \u064a\u0639\u062a\u0645\u062f \u0639\u0644\u0649 \u0627\u0644\u062c\u0631\u0639\u0629 \u0641\u064a \u062d\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.<\/p>\n<p><b>\u0646\u0628\u0630\u0629 \u0639\u0646 \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u064a\u0643\u0633 \u0625\u0646\u0643.<br class=\"dnr\" \/><\/b>\u062a\u0639\u0645\u0644 \u0634\u0631\u0643\u0629 Nanoscope Therapeutics \u0639\u0644\u0649 \u062a\u0637\u0648\u064a\u0631 \u0639\u0644\u0627\u062c\u0627\u062a \u0628\u0635\u0631\u064a\u0629 \u0648\u0631\u0627\u062b\u064a\u0629 \u0644\u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631\u060c \u0628\u063a\u0636 \u0627\u0644\u0646\u0638\u0631 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a\u060c \u0644\u0645\u0644\u0627\u064a\u064a\u0646 \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u0641\u0642\u062f\u0648\u0627 \u0628\u0635\u0631\u0647\u0645 \u0628\u0633\u0628\u0628 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629 \u0627\u0644\u062a\u064a \u0644\u0627 \u064a\u0648\u062c\u062f \u0644\u0647\u0627 \u0639\u0644\u0627\u062c. \u0648\u0642\u062f \u0623\u0643\u0645\u0644 \u0645\u0646\u062a\u062c \u0627\u0644\u0634\u0631\u0643\u0629 \u0627\u0644\u0631\u0626\u064a\u0633\u064a\u060c MCO-010\u060c \u0645\u0624\u062e\u0631\u064b\u0627 \u0645\u0631\u062d\u0644\u0629 RESTORE\u00a0<span class=\"xn-money\">2\u0628<\/span>\u00a0\u062a\u062c\u0631\u0628\u0629 \u0633\u0631\u064a\u0631\u064a\u0629 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u0645\u0631\u0627\u0643\u0632\u060c \u0639\u0634\u0648\u0627\u0626\u064a\u0629\u060c \u0645\u0632\u062f\u0648\u062c\u0629 \u0627\u0644\u0642\u0646\u0627\u0639\u060c \u062e\u0627\u0636\u0639\u0629 \u0644\u0644\u062a\u062d\u0643\u0645 \u0627\u0644\u0648\u0647\u0645\u064a \u0641\u064a \u0627\u0644\u0648\u0644\u0627\u064a\u0627\u062a \u0627\u0644\u0645\u062a\u062d\u062f\u0629 \u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a (NCT04945772). \u0643\u0645\u0627 \u0623\u0643\u0645\u0644\u062a \u0627\u0644\u0634\u0631\u0643\u0629 \u0645\u0624\u062e\u0631\u064b\u0627 \u062a\u062c\u0631\u0628\u0629 \u0627\u0644\u0645\u0631\u062d\u0644\u0629 \u0627\u0644\u062b\u0627\u0646\u064a\u0629 \u0645\u0646 \u0639\u0644\u0627\u062c STARLIGHT \u0644\u0639\u0644\u0627\u062c MCO-010 \u0641\u064a \u0627\u0644\u0645\u0631\u0636\u0649 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0645\u0631\u0636 Stargardt (NCT05417126). \u062d\u0635\u0644 MCO-010 \u0639\u0644\u0649 \u062a\u0633\u0645\u064a\u0627\u062a \u0627\u0644\u0645\u0633\u0627\u0631 \u0627\u0644\u0633\u0631\u064a\u0639 \u0645\u0646 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 (FDA) \u0648\u062a\u0633\u0645\u064a\u0627\u062a \u0627\u0644\u0623\u062f\u0648\u064a\u0629 \u0627\u0644\u064a\u062a\u064a\u0645\u0629 \u0645\u0646 \u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 (FDA) \u0644\u0643\u0644 \u0645\u0646 \u0645\u0631\u0636 RP \u0648Stargardt. \u062a\u0634\u0645\u0644 \u0627\u0644\u0623\u0635\u0648\u0644 \u0645\u0627 \u0642\u0628\u0644 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062c\u064a\u0646\u064a MCO-020 \u063a\u064a\u0631 \u0627\u0644\u0641\u064a\u0631\u0648\u0633\u064a \u0627\u0644\u0630\u064a \u064a\u062a\u0645 \u062a\u0633\u0644\u064a\u0645\u0647 \u0628\u0627\u0644\u0644\u064a\u0632\u0631 \u0644\u0640 GA \u0628\u0633\u0628\u0628 AMD.<\/p>\n<p><b>\u0627\u0644\u0627\u062a\u0635\u0627\u0644 \u0628\u0627\u0644\u0645\u0633\u062a\u062b\u0645\u0631:<\/b><br class=\"dnr\" \/>\u0634\u0631\u0643\u0627\u0621 \u0623\u0631\u063a\u0648\u062a<br class=\"dnr\" \/>212-600-1902<br class=\"dnr\" \/><a href=\"mailto:Nanoscope@argotpartners.com\" target=\"_blank\" rel=\"nofollow noopener\">Nanoscope@argotpartners.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"<p>MCO-010 achieved its primary and key secondary endpoints with statistical significance and no serious adverse events Data from the Phase\u00a02b\u00a0RESTORE trial demonstrate clinically meaningful vision improvement in legally blind individuals with progressive and permanent neurodegeneration of the retina RESTORE is the first randomized, controlled trial of a mutation-agnostic gene therapy for a genetic disease Nanoscope [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5671,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5670","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ar\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ar\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-26T11:39:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:20:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/03\/NSCOPE_Feature_ResultsPR.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1374\" \/>\n\t<meta property=\"og:image:height\" content=\"944\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/03\/NSCOPE_Feature_ResultsPR.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 \u062f\u0642\u0627\u0626\u0642\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa\",\"datePublished\":\"2024-03-26T11:39:12+00:00\",\"dateModified\":\"2025-06-27T16:20:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/\"},\"wordCount\":1573,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/NSCOPE_Feature_ResultsPR.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ar\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/\",\"name\":\"Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/NSCOPE_Feature_ResultsPR.jpg\",\"datePublished\":\"2024-03-26T11:39:12+00:00\",\"dateModified\":\"2025-06-27T16:20:37+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/NSCOPE_Feature_ResultsPR.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/NSCOPE_Feature_ResultsPR.jpg\",\"width\":1374,\"height\":944},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/03\\\/26\\\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0623\u0639\u0644\u0646\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u0639\u0646 \u0646\u062a\u0627\u0626\u062c \u0623\u0648\u0644\u064a\u0629 \u0625\u064a\u062c\u0627\u0628\u064a\u0629 \u0645\u0646 \u062a\u062c\u0631\u0628\u0629 \u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u0645\u0636\u0628\u0648\u0637\u0629 \u0644\u0639\u0642\u0627\u0631 MCO-010 \u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a - \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ar\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/","og_locale":"ar_AR","og_type":"article","og_title":"Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ar\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-03-26T11:39:12+00:00","article_modified_time":"2025-06-27T16:20:37+00:00","og_image":[{"width":1374,"height":944,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/03\/NSCOPE_Feature_ResultsPR.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/03\/NSCOPE_Feature_ResultsPR.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"Nanoscope Therapeutics","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"8 \u062f\u0642\u0627\u0626\u0642"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa","datePublished":"2024-03-26T11:39:12+00:00","dateModified":"2025-06-27T16:20:37+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/"},"wordCount":1573,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/03\/NSCOPE_Feature_ResultsPR.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ar"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/","url":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/","name":"\u0623\u0639\u0644\u0646\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u0639\u0646 \u0646\u062a\u0627\u0626\u062c \u0623\u0648\u0644\u064a\u0629 \u0625\u064a\u062c\u0627\u0628\u064a\u0629 \u0645\u0646 \u062a\u062c\u0631\u0628\u0629 \u0639\u0634\u0648\u0627\u0626\u064a\u0629 \u0645\u0636\u0628\u0648\u0637\u0629 \u0644\u0639\u0642\u0627\u0631 MCO-010 \u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a - \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/03\/NSCOPE_Feature_ResultsPR.jpg","datePublished":"2024-03-26T11:39:12+00:00","dateModified":"2025-06-27T16:20:37+00:00","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/03\/NSCOPE_Feature_ResultsPR.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/03\/NSCOPE_Feature_ResultsPR.jpg","width":1374,"height":944},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/03\/26\/nanoscope-therapeutics-announces-top-line-results-from-ph2-trial-of-mco-010-for-retinitis-pigmentosa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628","description":"\u0625\u0639\u0627\u062f\u0629 \u0646\u0648\u0631 \u0627\u0644\u0623\u0645\u0644","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/5670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/comments?post=5670"}],"version-history":[{"count":4,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/5670\/revisions"}],"predecessor-version":[{"id":9051,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/posts\/5670\/revisions\/9051"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media\/5671"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media?parent=5670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/categories?post=5670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/tags?post=5670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}